Your browser doesn't support javascript.
loading
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
Simmons, Archana R; Fourkala, Evangelia Ourania; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sutton, Margie N; Baggerly, Keith; Zheng, Hui; Lu, Karen H; Jacobs, Ian; Skates, Steven; Menon, Usha; Bast, Robert C.
Afiliación
  • Simmons AR; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Fourkala EO; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Gentry-Maharaj A; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Ryan A; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Sutton MN; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Baggerly K; Department of Bioinformatics, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zheng H; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jacobs I; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Skates S; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Menon U; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Bast RC; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas. rbast@mdanderson.org.
Cancer Prev Res (Phila) ; 12(6): 391-400, 2019 06.
Article en En | MEDLINE | ID: mdl-30967390
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_ovary_cancer Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Neoplasias Endometriales / Cistadenocarcinoma Seroso / Adenocarcinoma de Células Claras / Adenocarcinoma Mucinoso / Antígeno Ca-125 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Prev Res (Phila) Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_ovary_cancer Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Neoplasias Endometriales / Cistadenocarcinoma Seroso / Adenocarcinoma de Células Claras / Adenocarcinoma Mucinoso / Antígeno Ca-125 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Prev Res (Phila) Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article